ISRCTN96803614已完成未知
The natural history of inclusion body myositis: an observational cohort study
niversity College London Hospitals NHS Foundation Trust (UK)0 个研究点目标入组 120 人开始时间: 2013年2月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
2013 Results article in https://www.ncbi.nlm.nih.gov/pubmed/23489664 results
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •Any person who meets the established diagnostic criteria for inclusion body myositis. The age criteria set above in section A16 are to allow for one criterion being age at onset of over 30, while the upper limit is set so as not to exclude any participant on the grounds of being too old.
- •Griggs' diagnostic criteria for IBM:
- •Clinical features:
- •1. Illness duration of more than six months
- •2. Male and female, age at onset greater than 30 years
- •3. Proximal and distal weakness of arms and legs, with finger flexion weakness, wrist flexion more than extension weakness, and quadriceps weakness.
- •Laboratory features:
- •1. Creatine kinase (CK) less than 12 times normal
- •2. Neurophysiology consistent with myopathy
- •Muscle biopsy features:
- •1. Inflammation with mononuclear cell invasion of non-necrotic fibres
- •2. Vacuolated fibres
- •3. Intracellular amyloid and/or 15?18 nm filaments on electron microscopy
- •If all the muscle biopsy features above are present, then the disease is labelled as definite (regardless of the presence or absence of other criteria). To meet the probable standard of disease, then the muscle biopsy must show at least inflammation and vacuolation of fibres, plus all the clinical and laboratory features above.
排除标准
- •Does not meet inclusion criteria
研究者
相似试验
已完成
不适用
Study and Treatment of Inflammatory Muscle DiseasesPolymyositisDermatomyositisNCT00001265National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)1,325
尚未招募
不适用
Reliability of knee-extensor strap stabilisatioACTRN12623000255684Murdoch University30
已完成
早期 1 期
Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body MyositisInclusion Body MyositisNCT00802815Washington University School of Medicine20
Unknown
不适用
Pharmacoepidemiologic General Research Extension: PGRx-sIBM StudySporadic Inclusion Body MyositisNCT02735447La-ser Europe Limited190
招募中
1 期
Cell Therapy for IBM by Muscle Injection of ADSVFInclusion Body MyositisNCT05032131Assistance Publique - Hôpitaux de Paris32
